Errors that occur while the brain is developing can lead to conditions such as autism and schizophrenia. They can also lead to rare disorders like Rett syndrome and MeCP2 duplication syndromes, which are characterized by severe cognitive and physical disabilities. Many people with these neurodevelopmental disorders have mutations in genes that encode proteins found at synapses, which are the junctions between neurons where the cells exchange information with one another. However, not everyone with these mutations develops a neurodevelopmental disorder, which indicates that other, non-genetic factors also play a part.

One of the main non-genetic factors that can influence the risk and severity of neurodevelopmental disorders is inflammation of the brain. Inflammation is a normal part of the body’s immune response to threats such as invading microorganisms or tissue damage. However, abnormal activation of the immune system in early life can trigger excessive inflammation. This increases the risk of a neurodevelopmental disorder, but it is not clear exactly how it does so.

Tomasoni et al. set out to test whether the missing link between inflammation and neurodevelopmental disorders might be damage to synapses. The experiments revealed that genetically modified mice with inflammation of the brain have abnormal synapses and are unable to learn properly. These mutant mice also have excessive levels of a protein that influences how synapses function called MeCP2, which is missing in the brains of people with Rett syndrome and abnormally increased in brains of patients affected by MeCP2 Duplication Syndrome. This is thus the first evidence that directly links inflammation of the brain to a synapse protein implicated in a disorder of brain development.

Tomasoni et al. also found that a drug called anakinra – which is used to treat an inflammatory disease called rheumatoid arthritis – reduced levels of MeCP2 in the mutant mice and improved their performance in cognitive tasks. Together, these results raise the possibility that anti-inflammatory medications may be beneficial in the treatment of neurodevelopment disorders.

Neurological disorders represent an enormous source of burden to the individual and to society, with many patients failing to respond to available medication. Growing evidence on genetic components of neurological diseases have been collected during recent years; notably, these genes overwhelmingly point to disorders of synaptic transmission, which led to the coinage of the term ‘synaptopathy’ to indicate a brain disease originating from a dysfunction of the synapse (Grant, 2012; Grabrucker, 2014). Disruption of synapse function may also be caused by environmental stimuli, with inflammatory cytokines affecting synaptic transmission and modifying the risk and severity of a variety of brain diseases, including autism spectrum disorders, schizophrenia and cognitive disabilities (Hagberg et al., 2012; Chugh et al., 2013; Steinman, 2013). Among the cytokines known to affect synaptic function, the proinflammatory cytokine IL-1β plays a critical role. IL-1β was found to impair brain-derived neurotrophic factor (BDNF)-induced expression of molecules critical for activity-dependent synaptic plasticity, including cAMP response element binding protein (CREB), Arc, and cofilin, thus reducing actin polymerization and impairing spine morphogenesis (Tong et al., 2012). In addition, IL-1β controls different neuronal functions, including excitability and transmitter release, via multiple biochemical pathways (Weber et al., 2010). However, no evidence has been reported yet that IL-1β may affect synapse development and function acting on molecular pathways known to be at the root of synaptopathies.

Genetic mouse models of immune deregulation may serve as reliable and reproducible systems for examination of the effects of inflammation on synapse structure and function and elucidation of the molecular processes involved. IL-1R8, also known as single Ig IL-1-Related Receptor (SIGIRR) or TIR8, belongs to the toll-like receptors (TLRs) and interleukin-1R-like receptors (ILRs), a family of conserved proteins involved in immunity and inflammation (Riva et al., 2012; Garlanda et al., 2013a). TLRs are receptors able to recognize specific pathogen-associated patterns (PAMPs) and necrotic cell-derived danger signals (DAMPs) and act as sensors for microorganisms and tissue damage, whereas the IL-1R subfamily includes components of signalling receptor complexes as well as molecules with regulatory function. IL-1R8 dampens the activation of the TLRs and IL-1R signalling pathways by intracellularly interfering with the association of adaptor molecules to the receptor complexes, including NF-κB and JNK (Riva et al., 2012; Garlanda et al., 2013b). As a consequence, IL-1R8-deficient mice display exaggerated symptoms of inflammatory conditions (Garlanda et al., 2007; Gulen et al., 2010; Drexler et al., 2010) and demonstrate pronounced susceptibility to the inflammatory challenge posed by microbial LPS (Garlanda et al., 2004). IL-1R8 is also present in the brain (Costelloe et al., 2008; Polentarutti et al., 2003). Genetic deficiency for IL-1R8 is associated with inflammatory changes in the brain, including increased levels of LPS-induced tumor necrosis factor α (TNFα) and IL-6 in microglia, higher expression of TLR4, and NF-κB activation (Watson et al., 2010). Reduced IL-1R8 expression has been described in patients affected by psoriatic arthritis (Batliwalla et al., 2005) while SIGIRR variants (characterized by defective SIGIRR function) have been found in humans in association with necrotizing enterocolitis (Sampath et al., 2015) and with systemic lupus erythematosus (SLE; [Zhu et al., 2014]), all pathologies being characterized by cognitive defects and neurodevelopmental impairment (Husted et al., 2013; Rees et al., 2007; Calderón et al., 2014; Muscal et al., 2010). Notably, IL-1R8-deficient mice are impaired in novel object recognition, spatial reference memory and long-term potentiation (LTP), defects that occur in the absence of any external inflammatory stimuli (Costello et al., 2011). However, the molecular mechanisms by which IL-1R8 deficiency results in brain defects are still completely unknown.

We used IL-1R8 deficient mice to investigate whether genetic hyperactivation of the IL-1R pathway affects synapse function impinging on molecular players involved in synaptopathies. We demonstrate that the activity of the IL-1R pathway directly affects, in neurons, the levels of expression of the methyl-CpG-binding protein 2 (MeCP2), a synaptopathy protein involved in neurological diseases -Rett syndrome and MeCP2 duplication syndrome- characterized by defective plasticity, impaired cognition and intellectual disability. We also show that pharmacological inhibition of IL-1R activity normalizes MeCP2 expression and cognitive deficits in IL1R8-deficient mice.

Finely tuned expression of immune molecules has been found to modulate CNS function (Deverman and Patterson, 2009), both throughout normal development and in pathological conditions. During development, immune molecules such as CXCR4, interferon γ, IL-1β, IL-6, IL-9, IL-10 and transforming growth factor β affect neurogenesis, neuronal migration, axon guidance, synapse formation, activity-dependent refinement of circuits and synaptic plasticity (Deverman and Patterson, 2009; Zhao and Schwartz, 1998). In line with this concept, mice genetically devoid of IL-1R8, a receptor which dampens the activation of the TLRs and IL-1R signalling pathways, are neurologically impaired, showing defects in novel place recognition task, spatial reference memory and LTP, defects that occur in the absence of any external inflammatory stimuli (Costello et al., 2011). However, the molecular processes at the basis of these defects are still elusive.

Our study provides two major breakthroughs in the field of the cross talk between nervous and immune systems: first, it demonstrates that hyperactivation of the IL1R pathway results in the overexpression of MeCP2, a synaptic factor that controls spine morphogenesis, synaptic transmission and plasticity, which is responsible for syndromes associated with intellectual disability such as Rett syndrome and MeCP2 duplication syndrome; second it provides the proof-of-concept that the synaptic and behavioral defects consequent to genetic hyperactivation of the IL-1R pathway can be rescued in the adult by pharmacological treatment with IL-1Ra. Of note, the acute application of IL-1β to mature neurons recapitulates similar synaptic defects and alterations of MeCP2 expression. Consistently, transcriptomic analysis of cortices from WT mice (treated or not with IL-1β) and from IL-1R8 KO animals (treated or not treated with Anakinra) show that a common set of genes is transcriptionally altered in WT mice treated with IL-1β and in IL-1R8 KO animals, including genes controlling synaptic function and spine morphogenesis. The expression of this set of genes is restored to normal levels by treatment with Anakinra in IL-1R8 KO mice. These findings have important repercussions in the clinic, as they could open the road to the use of anti-inflammatory drugs as therapeutic treatments for neuropsychiatric illnesses such as schizophrenia, autism and mental retardation, for all of which an immune component has been demonstrated (Khandaker et al., 2015; Theoharides et al., 2015; Young et al., 2016).

Our study identifies the crucial involvement of the AKT/mTOR pathway in IL-1R8 KO neurons (Figure 10H). IL-1R8 has been previously reported to regulate mTOR kinase activity in Th17 cells, playing a nonredundant role in controlling mTOR-dependent differentiation, proliferation and cytokine production (Gulen et al., 2010). The demonstration that the PI3K/Akt/mTOR pathway is at the root of synaptic defects in IL-1R8 KO neurons is in line with the established involvement of this pathway in dendritic tree development and spine formation in neurons (Sarbassov et al., 2006), as well as actin cytoskeleton dynamics and synaptic plasticity (Jaworski and Sheng, 2006). Remarkably, the mTOR pathway is closely linked to ILR/TLR signaling since PI3 kinase is required for activation of NF-κB by IL-1 (Gulen et al., 2010). Furthermore, the signaling module containing the MyD88 adaptor protein, together with phosphorylated IRAK and TRAF6, which is downstream to both IL-1R and TLRs activation, is essential for PI3K recruitment and Akt activation, making mTOR one of the downstream targets of ILR/TLRs signaling (Gulen et al., 2010). Consistent with the involvement of mTOR in the IL-1R8 KO neuron defects, treatment with the PI3 kinase inhibitors, LY294002 and wortmannin restored the neuronal ability to sustain LTP. Moreover, specific inhibition of mTOR by the drug rapamycin rescues synaptic morphology in IL-1R8 KO neurons. These results indicate that the PI3K-regulated pathway is involved in the downstream signaling that connects excessive IL-1R activation to the morphological and functional impairments of dendritic spines observed in IL-1R8 KO neurons.

More importantly, our study shows for the first time that activation of IL-1R in neurons increases the levels of MeCP2, both in vitro and in vivo. Fine-tuning of MeCP2 expression is required for proper synapse function (reviewed in Na et al. [2013]). Indeed, lack of expression of MeCP2 results in deceleration of body and head growth rate, problems in motor and speech capabilities, irregularities in motor activity and difficulties in breathing, and also in cognitive defects characteristic of an autism-spectrum disorder (reviewed in Percy and Lane [2005]). Mouse models of MeCP2 duplication display a neurological phenotype, stereotyped and repetitive movements, epilepsy, spasticity, hypoactivity, early death (Collins et al., 2004) and defects in dendritic arborization and spine morphology (Jiang et al., 2013). In humans, sporadic mutations in the gene coding for MeCP2 results in Rett syndrome (Amir et al., 1999), while a double dosage of MeCP2 causes a severe developmental delay and mental retardation (Lubs et al., 1999). Thus, MeCP2 levels must be finely tuned as even mild over-expression of this factor can have a robust effect. We first demonstrate here that immune activation controls the expression of MeCP2 in neurons. The possibility that MeCP2 phosphorylation, by which MeCP2 also modulates gene expression levels, is altered in these models is an open issue. MeCP2 can act as a transcriptional activator (when interacting with CREB) but primarily functions as a transcriptional repressor associated with mSin3A and HDACs repressor complexes (Chahrour et al., 2008; Jones et al., 1998; Nan et al., 1998). Consistently, we observed a prevalence of downregulation over upregulation in the expression of the deregulated genes in WT mice treated with IL-1β and in IL-1R8 KO animals, suggesting that the repressor function of MeCP2 might dominate in response to IL-1R activity. Indeed, gene ontology enrichment analysis for the deregulated genes highlighted negative regulation of transcription from RNA polymerase II promoter and negative regulation of gene expression among the most affected biological processes in IL-1R8 KO animals (Supplementary file 4).

The regulation of MeCP2 protein levels by IL-1R8 appears to result from enhanced activity of IL-1R. IL-1β is a fundamental factor of inflammatory responses in the brain. It is expressed at baseline levels in the healthy brain, and its expression increases following peripheral infection, surgery, or brain injury, as well as in neurodegenerative diseases (Rothwell and Luheshi, 2000). Increases in IL-1β levels lead to cognitive decline, in particular in hippocampal-dependent tasks (Rachal Pugh et al., 2001). IL-1β overexpression for two weeks in an inducible transgenic mouse was found to cause impairment in long-term contextual and spatial memory, without effects on short-term and non-hippocampal memory (Hein et al., 2010). An increase in IL-1β levels due to Escherichia coli infection leads to defects in contextual fear conditioning, with loss of memory prevented by IL1Ra (Barrientos et al., 2009; Frank et al., 2010). Remarkably, we show that neuron treatment with IL-1β not only leads to an increase in immature spines unable to undergo LTP, but also augments MeCP2 levels. In this context, as with E. coli infection, IL1Ra/Anakinra restores synaptic function.

Our demonstration that enhanced IL-1R activity, due to either lack of IL-1R8 or excessive IL-1β signaling, impacts synapse function through regulating the expression of MeCP2 expands in a critical way previous research on the role of MeCP2 in cognition (Na et al., 2013): we show here that MeCP2 is a fundamental node linking inflammation with synaptic damage and we demonstrate that inhibition of IL-1R pathway by IL-1Ra restores synaptic structure and function in vitro. We also demonstrate that the acute treatment with Anakinra, a pharmacological agent currently in use to treat chronic inflammation, restores synaptic plasticity in vivo. Although we do not have the proof that this occurs exclusively through MeCP2 reduction, our data indicate that immune drugs may be efficacious for treating neurological deficits associated with immune pathologies with a genetic basis and justify further research into anti-inflammatory treatment for selected brain pathologies. Indeed, recurrent infections have been found to occur in 70% of individuals affected by MeCP2 duplication syndrome, which lead to further deterioration of the general and neurological status, being even fatal in some patients (van Esch et al., 2012). Also, in patients affected by cryopyrin-associated periodic syndrome (CAPS), a group of rare autoinflammatory diseases with genetic basis, the levels of IL-1β are fivefold higher than in healthy individuals, leading to persistent unregulated systemic inflammation (Janssen et al., 2004; Lachmann et al., 2009). CAPS is characterized by recurrent bouts of fever with malaise and chills, urticarial neutrophilic, eye redness due to conjunctivitis, arthralgia and myalgia with intense fatigue. Children affected by CAPS are believed to show symptoms of intellectual disability. Mental and hearing defects are reversed following treatment with Anakinra (Goldbach-Mansky, 2011; Goldbach-Mansky et al., 2006; Lepore et al., 2010; Miyamae et al., 2010; Neven et al., 2010) and with specific neutralization of IL-1β with canakinumab. Our study opens the possibility that further cognitive deterioration may result from the enhanced inflammation and hyperactivation of the IL-1 signaling pathway, which might further increase MeCP2 levels in a harmful positive feedback loop. The challenging possibility that treatment with Anakinra may help interrupting this spiral and ameliorating the cognitive deficits in affected individuals is worth to be tested.

1. 1. Romana Tomasoni
   2. Jose P Lopez-Atalaya
   3. Angel Barco
   4. Michela Matteoli

   (2017) Quantitative Analysis of cortical transcriptomes through Next Generation Sequencing from wild-type mice, wild-type mice treated with IL1b, IL-1R8 KO mice and IL-1R8 KO mice treated with IL1b antagonist Anakinra

   Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE80446.

   https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80446

1. 1. Amir RE
   2. Van den Veyver IB
   3. Wan M
   4. Tran CQ
   5. Francke U
   6. Zoghbi HY

   (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

   Nature Genetics 23:185–188.

   https://doi.org/10.1038/13810

   • PubMed
   • Google Scholar
2. 1. Anders S
   2. Pyl PT
   3. Huber W

   (2015) HTSeq--a Python framework to work with high-throughput sequencing data

   Bioinformatics 31:166–169.

   https://doi.org/10.1093/bioinformatics/btu638

   • PubMed
   • Google Scholar
3. 1. Asaka Y
   2. Jugloff DG
   3. Zhang L
   4. Eubanks JH
   5. Fitzsimonds RM

   (2006) Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of rett syndrome

   Neurobiology of Disease 21:217–227.

   https://doi.org/10.1016/j.nbd.2005.07.005

   • PubMed
   • Google Scholar
4. 1. Avital A
   2. Goshen I
   3. Kamsler A
   4. Segal M
   5. Iverfeldt K
   6. Richter-Levin G
   7. Yirmiya R

   (2003) Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity

   Hippocampus 13:826–834.

   https://doi.org/10.1002/hipo.10135

   • PubMed
   • Google Scholar
5. 1. Barrientos RM
   2. Frank MG
   3. Hein AM
   4. Higgins EA
   5. Watkins LR
   6. Rudy JW
   7. Maier SF

   (2009) Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection

   Brain, Behavior, and Immunity 23:46–54.

   https://doi.org/10.1016/j.bbi.2008.07.002

   • PubMed
   • Google Scholar
6. 1. Batliwalla FM
   2. Baechler EC
   3. Xiao X
   4. Li W
   5. Balasubramanian S
   6. Khalili H
   7. Damle A
   8. Ortmann WA
   9. Perrone A
   10. Kantor AB
   11. Gulko PS
   12. Kern M
   13. Furie R
   14. Behrens TW
   15. Gregersen PK

   (2005) Peripheral blood gene expression profiling in rheumatoid arthritis

   Genes and Immunity 6:388–397.

   https://doi.org/10.1038/sj.gene.6364209

   • PubMed
   • Google Scholar
7. 1. Bedogni F
   2. Cobolli Gigli C
   3. Pozzi D
   4. Rossi RL
   5. Scaramuzza L
   6. Rossetti G
   7. Pagani M
   8. Kilstrup-Nielsen C
   9. Matteoli M
   10. Landsberger N

   (2016) Defects during Mecp2 null embryonic cortex development precede the onset of overt neurological symptoms

   Cerebral Cortex 26:2517–2529.

   https://doi.org/10.1093/cercor/bhv078

   • PubMed
   • Google Scholar
8. 1. Blackman MP
   2. Djukic B
   3. Nelson SB
   4. Turrigiano GG

   (2012) A critical and cell-autonomous role for MeCP2 in synaptic scaling up

   Journal of Neuroscience 32:13529–13536.

   https://doi.org/10.1523/JNEUROSCI.3077-12.2012

   • PubMed
   • Google Scholar
9. 1. Bolger AM
   2. Lohse M
   3. Usadel B

   (2014) Trimmomatic: a flexible trimmer for illumina sequence data

   Bioinformatics 30:2114–2120.

   https://doi.org/10.1093/bioinformatics/btu170

   • PubMed
   • Google Scholar
10. 1. Calderón J
    2. Flores P
    3. Babul M
    4. Aguirre JM
    5. Slachevsky A
    6. Padilla O
    7. Scoriels L
    8. Henríquez C
    9. Cárcamo C
    10. Bravo-Zehnder M
    11. González A
    12. Massardo L

    (2014) Systemic lupus erythematosus impairs memory cognitive tests not affected by depression

    Lupus 23:1042–1053.

    https://doi.org/10.1177/0961203314536247

    • PubMed
    • Google Scholar
11. 1. Chahrour M
    2. Jung SY
    3. Shaw C
    4. Zhou X
    5. Wong ST
    6. Qin J
    7. Zoghbi HY

    (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription

    Science 320:1224–1229.

    https://doi.org/10.1126/science.1153252

    • PubMed
    • Google Scholar
12. 1. Chahrour M
    2. Zoghbi HY

    (2007) The story of rett syndrome: from clinic to neurobiology

    Neuron 56:422–437.

    https://doi.org/10.1016/j.neuron.2007.10.001

    • PubMed
    • Google Scholar
13. 1. Chao HT
    2. Zoghbi HY
    3. Rosenmund C

    (2007) MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number

    Neuron 56:58–65.

    https://doi.org/10.1016/j.neuron.2007.08.018

    • PubMed
    • Google Scholar
14. 1. Chugh D
    2. Nilsson P
    3. Afjei SA
    4. Bakochi A
    5. Ekdahl CT

    (2013) Brain inflammation induces post-synaptic changes during early synapse formation in adult-born hippocampal neurons

    Experimental Neurology 250:176–188.

    https://doi.org/10.1016/j.expneurol.2013.09.005

    • PubMed
    • Google Scholar
15. 1. Collins AL
    2. Levenson JM
    3. Vilaythong AP
    4. Richman R
    5. Armstrong DL
    6. Noebels JL
    7. David Sweatt J
    8. Zoghbi HY

    (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice

    Human Molecular Genetics 13:2679–2689.

    https://doi.org/10.1093/hmg/ddh282

    • PubMed
    • Google Scholar
16. 1. Coogan AN
    2. O'Connor JJ

    (1999) Interleukin-1beta inhibits a tetraethylammonium-induced synaptic potentiation in the rat dentate gyrus in vitro

    European Journal of Pharmacology 374:197–206.

    https://doi.org/10.1016/S0014-2999(99)00320-9

    • PubMed
    • Google Scholar
17. 1. Corradini I
    2. Donzelli A
    3. Antonucci F
    4. Welzl H
    5. Loos M
    6. Martucci R
    7. De Astis S
    8. Pattini L
    9. Inverardi F
    10. Wolfer D
    11. Caleo M
    12. Bozzi Y
    13. Verderio C
    14. Frassoni C
    15. Braida D
    16. Clerici M
    17. Lipp HP
    18. Sala M
    19. Matteoli M

    (2012) Epileptiform activity and cognitive deficits in SNAP-25(+/-) mice are normalized by antiepileptic drugs

    Cerebral Cortex 24:364–376.

    https://doi.org/10.1093/cercor/bhs316

    • PubMed
    • Google Scholar
18. 1. Costello DA
    2. Watson MB
    3. Cowley TR
    4. Murphy N
    5. Murphy Royal C
    6. Garlanda C
    7. Lynch MA

    (2011) Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice

    Journal of Neuroscience 31:3871–3879.

    https://doi.org/10.1523/JNEUROSCI.6676-10.2011

    • PubMed
    • Google Scholar
19. 1. Costelloe C
    2. Watson M
    3. Murphy A
    4. McQuillan K
    5. Loscher C
    6. Armstrong ME
    7. Garlanda C
    8. Mantovani A
    9. O'Neill LA
    10. Mills KH
    11. Lynch MA

    (2008) IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8

    Journal of Neurochemistry 105:1960–1969.

    https://doi.org/10.1111/j.1471-4159.2008.05304.x

    • PubMed
    • Google Scholar
20. 1. Deacon RM
    2. Rawlins JN

    (2006) T-maze alternation in the rodent

    Nature Protocols 1:7–12.

    https://doi.org/10.1038/nprot.2006.2

    • PubMed
    • Google Scholar
21. 1. Deverman BE
    2. Patterson PH

    (2009) Cytokines and CNS development

    Neuron 64:61–78.

    https://doi.org/10.1016/j.neuron.2009.09.002

    • PubMed
    • Google Scholar
22. 1. Dinarello CA

    (2009) Immunological and inflammatory functions of the interleukin-1 family

    Annual Review of Immunology 27:519–550.

    https://doi.org/10.1146/annurev.immunol.021908.132612

    • PubMed
    • Google Scholar
23. 1. Drexler SK
    2. Kong P
    3. Inglis J
    4. Williams RO
    5. Garlanda C
    6. Mantovani A
    7. Yazdi AS
    8. Brennan F
    9. Feldmann M
    10. Foxwell BM

    (2010) SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis

    Arthritis & Rheumatism 62:2249–2261.

    https://doi.org/10.1002/art.27517

    • PubMed
    • Google Scholar
24. 1. Frank MG
    2. Barrientos RM
    3. Hein AM
    4. Biedenkapp JC
    5. Watkins LR
    6. Maier SF

    (2010) IL-1RA blocks E. coli-induced suppression of arc and long-term memory in aged F344xBN F1 rats

    Brain, Behavior, and Immunity 24:254–262.

    https://doi.org/10.1016/j.bbi.2009.10.005

    • PubMed
    • Google Scholar
25. 1. Gangisetty O
    2. Bekdash R
    3. Maglakelidze G
    4. Sarkar DK

    (2014) Fetal alcohol exposure alters proopiomelanocortin gene expression and hypothalamic-pituitary-adrenal axis function via increasing MeCP2 expression in the hypothalamus

    PLoS One 9:e113228.

    https://doi.org/10.1371/journal.pone.0113228

    • PubMed
    • Google Scholar
26. 1. Garlanda C
    2. Dinarello CA
    3. Mantovani A

    (2013a) The interleukin-1 family: back to the future

    Immunity 39:1003–1018.

    https://doi.org/10.1016/j.immuni.2013.11.010

    • PubMed
    • Google Scholar
27. 1. Garlanda C
    2. Riva F
    3. Bonavita E
    4. Gentile S
    5. Mantovani A

    (2013b) Decoys and regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily

    Frontiers in Immunology 4:180.

    https://doi.org/10.3389/fimmu.2013.00180

    • PubMed
    • Google Scholar
28. 1. Garlanda C
    2. Riva F
    3. Polentarutti N
    4. Buracchi C
    5. Sironi M
    6. De Bortoli M
    7. Muzio M
    8. Bergottini R
    9. Scanziani E
    10. Vecchi A
    11. Hirsch E
    12. Mantovani A

    (2004) Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family

    PNAS 101:3522–3526.

    https://doi.org/10.1073/pnas.0308680101

    • PubMed
    • Google Scholar
29. 1. Garlanda C
    2. Riva F
    3. Veliz T
    4. Polentarutti N
    5. Pasqualini F
    6. Radaelli E
    7. Sironi M
    8. Nebuloni M
    9. Zorini EO
    10. Scanziani E
    11. Mantovani A

    (2007) Increased susceptibility to colitis-associated Cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family

    Cancer Research 67:6017–6021.

    https://doi.org/10.1158/0008-5472.CAN-07-0560

    • PubMed
    • Google Scholar
30. 1. Goldbach-Mansky R
    2. Dailey NJ
    3. Canna SW
    4. Gelabert A
    5. Jones J
    6. Rubin BI
    7. Kim HJ
    8. Brewer C
    9. Zalewski C
    10. Wiggs E
    11. Hill S
    12. Turner ML
    13. Karp BI
    14. Aksentijevich I
    15. Pucino F
    16. Penzak SR
    17. Haverkamp MH
    18. Stein L
    19. Adams BS
    20. Moore TL
    21. Fuhlbrigge RC
    22. Shaham B
    23. Jarvis JN
    24. O'Neil K
    25. Vehe RK
    26. Beitz LO
    27. Gardner G
    28. Hannan WP
    29. Warren RW
    30. Horn W
    31. Cole JL
    32. Paul SM
    33. Hawkins PN
    34. Pham TH
    35. Snyder C
    36. Wesley RA
    37. Hoffmann SC
    38. Holland SM
    39. Butman JA
    40. Kastner DL

    (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

    New England Journal of Medicine 355:581–592.

    https://doi.org/10.1056/NEJMoa055137

    • PubMed
    • Google Scholar
31. 1. Goldbach-Mansky R

    (2011) Current status of understanding the pathogenesis and management of patients with NOMID/CINCA

    Current Rheumatology Reports 13:123–131.

    https://doi.org/10.1007/s11926-011-0165-y

    • PubMed
    • Google Scholar
32. 1. Grabrucker AM

    (2014) A role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders

    Developmental Neurobiology 74:136–146.

    https://doi.org/10.1002/dneu.22089

    • PubMed
    • Google Scholar
33. 1. Grant SG

    (2012) Synaptopathies: diseases of the synaptome

    Current Opinion in Neurobiology 22:522–529.

    https://doi.org/10.1016/j.conb.2012.02.002

    • PubMed
    • Google Scholar
34. 1. Gulen MF
    2. Kang Z
    3. Bulek K
    4. Youzhong W
    5. Kim TW
    6. Chen Y
    7. Altuntas CZ
    8. Sass Bak-Jensen K
    9. McGeachy MJ
    10. Do JS
    11. Xiao H
    12. Delgoffe GM
    13. Min B
    14. Powell JD
    15. Tuohy VK
    16. Cua DJ
    17. Li X

    (2010) The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation

    Immunity 32:54–66.

    https://doi.org/10.1016/j.immuni.2009.12.003

    • PubMed
    • Google Scholar
35. 1. Guy J
    2. Gan J
    3. Selfridge J
    4. Cobb S
    5. Bird A

    (2007) Reversal of neurological defects in a mouse model of Rett syndrome

    Science 315:1143–1147.

    https://doi.org/10.1126/science.1138389

    • PubMed
    • Google Scholar
36. 1. Hagberg H
    2. Gressens P
    3. Mallard C
    4. fetal Iduring

    (2012) Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults

    Annals of Neurology 71:444–457.

    https://doi.org/10.1002/ana.22620

    • PubMed
    • Google Scholar
37. 1. Hein AM
    2. Stasko MR
    3. Matousek SB
    4. Scott-McKean JJ
    5. Maier SF
    6. Olschowka JA
    7. Costa AC
    8. O'Banion MK

    (2010) Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice

    Brain, Behavior, and Immunity 24:243–253.

    https://doi.org/10.1016/j.bbi.2009.10.002

    • PubMed
    • Google Scholar
38. 1. Hoeffer CA
    2. Klann E

    (2010) mTOR signaling: at the crossroads of plasticity, memory and disease

    Trends in Neurosciences 33:67–75.

    https://doi.org/10.1016/j.tins.2009.11.003

    • PubMed
    • Google Scholar
39. 1. Husted JA
    2. Thavaneswaran A
    3. Chandran V
    4. Gladman DD

    (2013) Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis

    The Journal of Rheumatology 40:1349–1356.

    https://doi.org/10.3899/jrheum.121500

    • PubMed
    • Google Scholar
40. 1. Janssen R
    2. Verhard E
    3. Lankester A
    4. Ten Cate R
    5. van Dissel JT

    (2004) Enhanced interleukin-1beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome

    Arthritis & Rheumatism 50:3329–3333.

    https://doi.org/10.1002/art.20494

    • PubMed
    • Google Scholar
41. 1. Jaworski J
    2. Sheng M

    (2006) The growing role of mTOR in neuronal development and plasticity

    Molecular Neurobiology 34:205–220.

    https://doi.org/10.1385/MN:34:3:205

    • PubMed
    • Google Scholar
42. 1. Jiang M
    2. Ash RT
    3. Baker SA
    4. Suter B
    5. Ferguson A
    6. Park J
    7. Rudy J
    8. Torsky SP
    9. Chao HT
    10. Zoghbi HY
    11. Smirnakis SM

    (2013) Dendritic arborization and spine dynamics are abnormal in the mouse model of MECP2 duplication syndrome

    Journal of Neuroscience 33:19518–19533.

    https://doi.org/10.1523/JNEUROSCI.1745-13.2013

    • PubMed
    • Google Scholar
43. 1. Jones PL
    2. Veenstra GJ
    3. Wade PA
    4. Vermaak D
    5. Kass SU
    6. Landsberger N
    7. Strouboulis J
    8. Wolffe AP

    (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

    Nature Genetics 19:187–191.

    https://doi.org/10.1038/561

    • PubMed
    • Google Scholar
44. 1. Khandaker GM
    2. Cousins L
    3. Deakin J
    4. Lennox BR
    5. Yolken R
    6. Jones PB

    (2015) Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

    The Lancet Psychiatry 2:258–270.

    https://doi.org/10.1016/S2215-0366(14)00122-9

    • PubMed
    • Google Scholar
45. 1. Kim D
    2. Pertea G
    3. Trapnell C
    4. Pimentel H
    5. Kelley R
    6. Salzberg SL

    (2013) TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

    Genome Biology 14:R36.

    https://doi.org/10.1186/gb-2013-14-4-r36

    • PubMed
    • Google Scholar
46. 1. Kishi N
    2. MacDonald JL
    3. Ye J
    4. Molyneaux BJ
    5. Azim E
    6. Macklis JD

    (2016) Reduction of aberrant NF-κB signalling ameliorates Rett syndrome phenotypes in Mecp2-null mice

    Nature Communications 7:10520.

    https://doi.org/10.1038/ncomms10520

    • PubMed
    • Google Scholar
47. 1. Lachmann HJ
    2. Lowe P
    3. Felix SD
    4. Rordorf C
    5. Leslie K
    6. Madhoo S
    7. Wittkowski H
    8. Bek S
    9. Hartmann N
    10. Bosset S
    11. Hawkins PN
    12. Jung T

    (2009) In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes

    The Journal of Experimental Medicine 206:1029–1036.

    https://doi.org/10.1084/jem.20082481

    • PubMed
    • Google Scholar
48. 1. Langmead B
    2. Trapnell C
    3. Pop M
    4. Salzberg SL

    (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

    Genome Biology 10:R25.

    https://doi.org/10.1186/gb-2009-10-3-r25

    • PubMed
    • Google Scholar
49. 1. Lee CC
    2. Huang CC
    3. Hsu KS

    (2011) Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways

    Neuropharmacology 61:867–879.

    https://doi.org/10.1016/j.neuropharm.2011.06.003

    • PubMed
    • Google Scholar
50. 1. Lepore L
    2. Paloni G
    3. Caorsi R
    4. Alessio M
    5. Rigante D
    6. Ruperto N
    7. Cattalini M
    8. Tommasini A
    9. Zulian F
    10. Ventura A
    11. Martini A
    12. Gattorno M

    (2010) Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra

    The Journal of Pediatrics 157:310–315.

    https://doi.org/10.1016/j.jpeds.2010.02.040

    • PubMed
    • Google Scholar
51. 1. Li H
    2. Handsaker B
    3. Wysoker A
    4. Fennell T
    5. Ruan J
    6. Homer N
    7. Marth G
    8. Abecasis G
    9. Durbin R
    10. 1000 Genome Project Data Processing Subgroup

    (2009) The sequence alignment/Map format and SAMtools

    Bioinformatics 25:2078–2079.

    https://doi.org/10.1093/bioinformatics/btp352

    • PubMed
    • Google Scholar
52. 1. Love MI
    2. Huber W
    3. Anders S

    (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

    Genome Biology 15:550.

    https://doi.org/10.1186/s13059-014-0550-8

    • PubMed
    • Google Scholar
53. 1. Lubs H
    2. Abidi F
    3. Bier JA
    4. Abuelo D
    5. Ouzts L
    6. Voeller K
    7. Fennell E
    8. Stevenson RE
    9. Schwartz CE
    10. Arena F

    (1999) XLMR syndrome characterized by multiple respiratory infections, hypertelorism, severe CNS deterioration and early death localizes to distal Xq28

    American Journal of Medical Genetics 85:243–248.

    https://doi.org/10.1002/(SICI)1096-8628(19990730)85:3<243::AID-AJMG11>3.0.CO;2-E

    • PubMed
    • Google Scholar
54. 1. Menna E
    2. Zambetti S
    3. Morini R
    4. Donzelli A
    5. Disanza A
    6. Calvigioni D
    7. Braida D
    8. Nicolini C
    9. Orlando M
    10. Fossati G
    11. Cristina Regondi M
    12. Pattini L
    13. Frassoni C
    14. Francolini M
    15. Scita G
    16. Sala M
    17. Fahnestock M
    18. Matteoli M

    (2013) Eps8 controls dendritic spine density and synaptic plasticity through its actin-capping activity

    The EMBO Journal 32:1730–1744.

    https://doi.org/10.1038/emboj.2013.107

    • PubMed
    • Google Scholar
55. 1. Miyamae T
    2. Inaba Y
    3. Nishimura G
    4. Kikuchi M
    5. Kishi T
    6. Hara R
    7. Kaneko U
    8. Shinoki T
    9. Imagawa T
    10. Yokokta S

    (2010) Effect of anakinra on arthropathy in CINCA/NOMID syndrome

    Pediatric Rheumatology 8:9.

    https://doi.org/10.1186/1546-0096-8-9

    • PubMed
    • Google Scholar
56. 1. Mollica L
    2. De Marchis F
    3. Spitaleri A
    4. Dallacosta C
    5. Pennacchini D
    6. Zamai M
    7. Agresti A
    8. Trisciuoglio L
    9. Musco G
    10. Bianchi ME

    (2007) Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities

    Chemistry & Biology 14:431–441.

    https://doi.org/10.1016/j.chembiol.2007.03.007

    • PubMed
    • Google Scholar
57. 1. Moretti P
    2. Levenson JM
    3. Battaglia F
    4. Atkinson R
    5. Teague R
    6. Antalffy B
    7. Armstrong D
    8. Arancio O
    9. Sweatt JD
    10. Zoghbi HY

    (2006) Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome

    Journal of Neuroscience 26:319–327.

    https://doi.org/10.1523/JNEUROSCI.2623-05.2006

    • PubMed
    • Google Scholar
58. 1. Moy SS
    2. Nadler JJ
    3. Young NB
    4. Nonneman RJ
    5. Segall SK
    6. Andrade GM
    7. Crawley JN
    8. Magnuson TR

    (2008) Social approach and repetitive behavior in eleven inbred mouse strains

    Behavioural Brain Research 191:118–129.

    https://doi.org/10.1016/j.bbr.2008.03.015

    • PubMed
    • Google Scholar
59. 1. Muscal E
    2. Bloom DR
    3. Hunter JV
    4. Myones BL

    (2010) Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution

    Lupus 19:268–279.

    https://doi.org/10.1177/0961203309352092

    • PubMed
    • Google Scholar
60. 1. Na ES
    2. Nelson ED
    3. Kavalali ET
    4. Monteggia LM

    (2013) The impact of MeCP2 loss- or gain-of-function on synaptic plasticity

    Neuropsychopharmacology 38:212–219.

    https://doi.org/10.1038/npp.2012.116

    • PubMed
    • Google Scholar
61. 1. Nan X
    2. Ng HH
    3. Johnson CA
    4. Laherty CD
    5. Turner BM
    6. Eisenman RN
    7. Bird A

    (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

    Nature 393:386–389.

    https://doi.org/10.1038/30764

    • PubMed
    • Google Scholar
62. 1. Nelson ED
    2. Kavalali ET
    3. Monteggia LM

    (2006) MeCP2-dependent transcriptional repression regulates excitatory neurotransmission

    Current Biology 16:710–716.

    https://doi.org/10.1016/j.cub.2006.02.062

    • PubMed
    • Google Scholar
63. 1. Neven B
    2. Marvillet I
    3. Terrada C
    4. Ferster A
    5. Boddaert N
    6. Couloignier V
    7. Pinto G
    8. Pagnier A
    9. Bodemer C
    10. Bodaghi B
    11. Tardieu M
    12. Prieur AM
    13. Quartier P

    (2010) Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome

    Arthritis & Rheumatism 62:258–267.

    https://doi.org/10.1002/art.25057

    • PubMed
    • Google Scholar
64. 1. Opazo P
    2. Watabe AM
    3. Grant SG
    4. O'Dell TJ

    (2003)

    Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms

    Journal of Neuroscience 23:3679–3688.

    • PubMed
    • Google Scholar
65. 1. Percy AK
    2. Lane JB

    (2005) Rett syndrome: model of neurodevelopmental disorders

    Journal of Child Neurology 20:718–721.

    https://doi.org/10.1177/08830738050200090301

    • PubMed
    • Google Scholar
66. 1. Pettem KL
    2. Yokomaku D
    3. Takahashi H
    4. Ge Y
    5. Craig AM

    (2013) Interaction between autism-linked MDGAs and neuroligins suppresses inhibitory synapse development

    The Journal of Cell Biology 200:321–336.

    https://doi.org/10.1083/jcb.201206028

    • PubMed
    • Google Scholar
67. 1. Polentarutti N
    2. Rol GP
    3. Muzio M
    4. Bosisio D
    5. Camnasio M
    6. Riva F
    7. Zoja C
    8. Benigni A
    9. Tomasoni S
    10. Vecchi A
    11. Garlanda C
    12. Mantovani A

    (2003)

    Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR

    European Cytokine Network 14:211–218.

    • PubMed
    • Google Scholar
68. 1. Rachal Pugh C
    2. Fleshner M
    3. Watkins LR
    4. Maier SF
    5. Rudy JW

    (2001) The immune system and memory consolidation: a role for the cytokine IL-1beta

    Neuroscience & Biobehavioral Reviews 25:29–41.

    https://doi.org/10.1016/S0149-7634(00)00048-8

    • PubMed
    • Google Scholar
69. 1. Ramocki MB
    2. Tavyev YJ
    3. Peters SU

    (2010) The MECP2 duplication syndrome

    American Journal of Medical Genetics Part A 152A:1079–1088.

    https://doi.org/10.1002/ajmg.a.33184

    • PubMed
    • Google Scholar
70. 1. Rees L
    2. Marshall S
    3. Hartridge C
    4. Mackie D
    5. Weiser M
    6. Erabi Group

    (2007) Cognitive interventions post acquired brain injury

    Brain Injury 21:161–200.

    https://doi.org/10.1080/02699050701201813

    • PubMed
    • Google Scholar
71. 1. Ricciardi S
    2. Boggio EM
    3. Grosso S
    4. Lonetti G
    5. Forlani G
    6. Stefanelli G
    7. Calcagno E
    8. Morello N
    9. Landsberger N
    10. Biffo S
    11. Pizzorusso T
    12. Giustetto M
    13. Broccoli V

    (2011) Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model

    Human Molecular Genetics 20:1182–1196.

    https://doi.org/10.1093/hmg/ddq563

    • PubMed
    • Google Scholar
72. 1. Riva F
    2. Bonavita E
    3. Barbati E
    4. Muzio M
    5. Mantovani A
    6. Garlanda C

    (2012) TIR8/SIGIRR is an Interleukin-1 receptor/Toll like receptor family member with regulatory functions in inflammation and immunity

    Frontiers in Immunology 3:322.

    https://doi.org/10.3389/fimmu.2012.00322

    • PubMed
    • Google Scholar
73. 1. Rothwell NJ
    2. Luheshi GN

    (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target

    Trends in Neurosciences 23:618–625.

    https://doi.org/10.1016/S0166-2236(00)01661-1

    • PubMed
    • Google Scholar
74. 1. Sakamoto R
    2. Okano M
    3. Takena H
    4. Ohtsuki K

    (2001) Inhibitory effect of glycyrrhizin on the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro

    Biological & Pharmaceutical Bulletin 24:906–911.

    https://doi.org/10.1248/bpb.24.906

    • PubMed
    • Google Scholar
75. 1. Sampath V
    2. Menden H
    3. Helbling D
    4. Li K
    5. Gastonguay A
    6. Ramchandran R
    7. Dimmock DP

    (2015) SIGIRR genetic variants in premature infants with necrotizing enterocolitis

    Pediatrics 135:e1530–e1534.

    https://doi.org/10.1542/peds.2014-3386

    • PubMed
    • Google Scholar
76. 1. Sarbassov DD
    2. Ali SM
    3. Sengupta S
    4. Sheen JH
    5. Hsu PP
    6. Bagley AF
    7. Markhard AL
    8. Sabatini DM

    (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and akt/PKB

    Molecular Cell 22:159–168.

    https://doi.org/10.1016/j.molcel.2006.03.029

    • PubMed
    • Google Scholar
77. 1. Schneider H
    2. Pitossi F
    3. Balschun D
    4. Wagner A
    5. del Rey A
    6. Besedovsky HO

    (1998) A neuromodulatory role of interleukin-1beta in the Hippocampus

    PNAS 95:7778–7783.

    https://doi.org/10.1073/pnas.95.13.7778

    • PubMed
    • Google Scholar
78. 1. Steinman L

    (2013) Inflammatory cytokines at the summits of pathological signal cascades in brain diseases

    Science Signaling 6:pe3.

    https://doi.org/10.1126/scisignal.2003898

    • PubMed
    • Google Scholar
79. 1. Tantra M
    2. Hammer C
    3. Kästner A
    4. Dahm L
    5. Begemann M
    6. Bodda C
    7. Hammerschmidt K
    8. Giegling I
    9. Stepniak B
    10. Castillo Venzor A
    11. Konte B
    12. Erbaba B
    13. Hartmann A
    14. Tarami A
    15. Schulz-Schaeffer W
    16. Rujescu D
    17. Mannan AU
    18. Ehrenreich H

    (2014) Mild expression differences of MECP2 influencing aggressive social behavior

    EMBO Molecular Medicine 6:662–684.

    https://doi.org/10.1002/emmm.201303744

    • PubMed
    • Google Scholar
80. 1. Theoharides TC
    2. Athanassiou M
    3. Panagiotidou S
    4. Doyle R

    (2015) Dysregulated brain immunity and neurotrophin signaling in rett syndrome and autism spectrum disorders

    Journal of Neuroimmunology 279:33–38.

    https://doi.org/10.1016/j.jneuroim.2014.12.003

    • PubMed
    • Google Scholar
81. 1. Tong L
    2. Prieto GA
    3. Kramár EA
    4. Smith ED
    5. Cribbs DH
    6. Lynch G
    7. Cotman CW

    (2012) Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1β via p38 mitogen-activated protein kinase

    Journal of Neuroscience 32:17714–17724.

    https://doi.org/10.1523/JNEUROSCI.1253-12.2012

    • PubMed
    • Google Scholar
82. 1. van Esch S
    2. Krediet RT
    3. Struijk DG

    (2012) Prognostic factors for peritonitis outcome

    Contributions to Nephrology 178:264–270.

    https://doi.org/10.1159/000337889

    • PubMed
    • Google Scholar
83. 1. Verderio C
    2. Coco S
    3. Fumagalli G
    4. Matteoli M

    (1994) Spatial changes in calcium signaling during the establishment of neuronal polarity and synaptogenesis

    The Journal of Cell Biology 126:1527–1536.

    https://doi.org/10.1083/jcb.126.6.1527

    • PubMed
    • Google Scholar
84. 1. Véliz Rodriguez T
    2. Moalli F
    3. Polentarutti N
    4. Paroni M
    5. Bonavita E
    6. Anselmo A
    7. Nebuloni M
    8. Mantero S
    9. Jaillon S
    10. Bragonzi A
    11. Mantovani A
    12. Riva F
    13. Garlanda C

    (2012) Role of Toll interleukin-1 receptor (IL-1R) 8, a negative regulator of IL-1R/Toll-like receptor signaling, in resistance to acute Pseudomonas aeruginosa lung infection

    Infection and Immunity 80:100–109.

    https://doi.org/10.1128/IAI.05695-11

    • PubMed
    • Google Scholar
85. 1. Vézina C
    2. Kudelski A
    3. Sehgal SN

    (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. I. taxonomy of the producing streptomycete and isolation of the active principle

    The Journal of Antibiotics 28:721–726.

    https://doi.org/10.7164/antibiotics.28.721

    • PubMed
    • Google Scholar
86. 1. Watson MB
    2. Costello DA
    3. Carney DG
    4. McQuillan K
    5. Lynch MA

    (2010) SIGIRR modulates the inflammatory response in the brain

    Brain, Behavior, and Immunity 24:985–995.

    https://doi.org/10.1016/j.bbi.2010.04.002

    • PubMed
    • Google Scholar
87. 1. Weber A
    2. Wasiliew P
    3. Kracht M

    (2010) Interleukin-1 (IL-1) pathway

    Science Signaling 3:cm1.

    https://doi.org/10.1126/scisignal.3105cm1

    • PubMed
    • Google Scholar
88. 1. Young AM
    2. Chakrabarti B
    3. Roberts D
    4. Lai MC
    5. Suckling J
    6. Baron-Cohen S

    (2016) From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition

    Molecular Autism 7:9.

    https://doi.org/10.1186/s13229-016-0068-x

    • PubMed
    • Google Scholar
89. 1. Zhang B
    2. Kirov S
    3. Snoddy J

    (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts

    Nucleic Acids Research 33:W741–W748.

    https://doi.org/10.1093/nar/gki475

    • PubMed
    • Google Scholar
90. 1. Zhao B
    2. Schwartz JP

    (1998) Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives

    Journal of Neuroscience Research 52:7–16.

    https://doi.org/10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I

    • PubMed
    • Google Scholar
91. 1. Zhou Z
    2. Hong EJ
    3. Cohen S
    4. Zhao WN
    5. Ho HY
    6. Schmidt L
    7. Chen WG
    8. Lin Y
    9. Savner E
    10. Griffith EC
    11. Hu L
    12. Steen JA
    13. Weitz CJ
    14. Greenberg ME

    (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent bdnf transcription, dendritic growth, and spine maturation

    Neuron 52:255–269.

    https://doi.org/10.1016/j.neuron.2006.09.037

    • PubMed
    • Google Scholar
92. 1. Zhu Y
    2. Wang DG
    3. Yang XK
    4. Tao SS
    5. Huang Q
    6. Pan HF
    7. Feng CC
    8. Ye DQ

    (2014) Emerging role of SIGIRR rs7396562(T/G) polymorphism in systemic lupus erythematosus in a Chinese population

    Inflammation 37:1847–1851.

    https://doi.org/10.1007/s10753-014-9916-z

    • PubMed
    • Google Scholar
93. 1. Zoghbi HY

    (2003) Postnatal neurodevelopmental disorders: meeting at the synapse?

    Science 302:826–830.

    https://doi.org/10.1126/science.1089071

    • PubMed
    • Google Scholar

Author details

1. Romana Tomasoni

   1. IRCCS Humanitas, Rozzano, Italy
   2. Instituto de Neurociencias (Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas), Alicante, Spain

   Contribution

   RT, Conceptualization, Data curation, Formal analysis, Investigation, Writing—original draft, Writing—review and editing

   Competing interests

   The authors declare that no competing interests exist.

   "This ORCID iD identifies the author of this article:" 0000-0002-3374-2698

2. Raffaella Morini

   IRCCS Humanitas, Rozzano, Italy

   Contribution

   RM, Data curation, Formal analysis, Investigation

   Competing interests

   The authors declare that no competing interests exist.

3. Jose P Lopez-Atalaya

   Instituto de Neurociencias (Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas), Alicante, Spain

   Contribution

   JPL-A, Conceptualization, Data curation, Formal analysis

   Competing interests

   The authors declare that no competing interests exist.

4. Irene Corradini

   1. IRCCS Humanitas, Rozzano, Italy
   2. IN-CNR, Milano, Italy

   Contribution

   IC, Data curation, Formal analysis, Investigation

   Competing interests

   The authors declare that no competing interests exist.

5. Alice Canzi

   1. IRCCS Humanitas, Rozzano, Italy
   2. Hunimed University, Rozzano, Italy

   Contribution

   AC, Data curation, Formal analysis, Investigation

   Competing interests

   The authors declare that no competing interests exist.

6. Marco Rasile

   1. IRCCS Humanitas, Rozzano, Italy
   2. Hunimed University, Rozzano, Italy

   Contribution

   MR, Data curation, Formal analysis, Investigation

   Competing interests

   The authors declare that no competing interests exist.

7. Cristina Mantovani

   IRCCS Humanitas, Rozzano, Italy

   Contribution

   CM, Data curation, Formal analysis, Investigation

   Competing interests

   The authors declare that no competing interests exist.

8. Davide Pozzi

   1. IRCCS Humanitas, Rozzano, Italy
   2. Hunimed University, Rozzano, Italy

   Contribution

   DP, Data curation, Formal analysis, Investigation

   Competing interests

   The authors declare that no competing interests exist.

9. Cecilia Garlanda

   IRCCS Humanitas, Rozzano, Italy

   Contribution

   CG, Conceptualization, Writing—original draft, Writing—review and editing

   Competing interests

   The authors declare that no competing interests exist.

10. Alberto Mantovani

    1. IRCCS Humanitas, Rozzano, Italy
    2. Hunimed University, Rozzano, Italy

    Contribution

    AM, Conceptualization, Writing—original draft, Writing—review and editing

    Competing interests

    The authors declare that no competing interests exist.

11. Elisabetta Menna

    1. IRCCS Humanitas, Rozzano, Italy
    2. IN-CNR, Milano, Italy

    Contribution

    EM, Conceptualization, Data curation, Formal analysis, Writing—original draft, Writing—review and editing

    Competing interests

    The authors declare that no competing interests exist.

12. Angel Barco

    Instituto de Neurociencias (Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas), Alicante, Spain

    Contribution

    AB, Data curation, Formal analysis, Writing—original draft

    Competing interests

    The authors declare that no competing interests exist.

13. Michela Matteoli

    1. IRCCS Humanitas, Rozzano, Italy
    2. IN-CNR, Milano, Italy

    Contribution

    MM, Conceptualization, Data curation, Supervision, Funding acquisition, Writing—original draft, Project administration, Writing—review and editing

    For correspondence

    michela.matteoli@humanitasresearch.it

    Competing interests

    The authors declare that no competing interests exist.

    "This ORCID iD identifies the author of this article:" 0000-0002-3569-7843

• 2,034

  views

• 378

  downloads

• 35

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.